Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N

Open source

DOI: 10.1182/blood-2018-06-858613
Published: 2018 Dec 6
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood-2018-06-858613,
  title = {Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.},
  author = {Perrot A and Lauwers-Cances V and Corre J and Robillard N and Hulin C and Chretien ML and Dejoie T and Maheo S and Stoppa AM and Pegourie B and Karlin L and Garderet L and Arnulf B and Doyen C and Meuleman N and Royer B and Eveillard JR and Benboubker L and Dib M and Decaux O and Jaccard A and Belhadj K and Brechignac S and Kolb B and Fohrer C and Mohty M and Macro M and Richardson PG and Carlton V and Moorhead M and Willis T and Faham M and Anderson KC and Harousseau JL and Leleu X and Facon T and Moreau P and Attal M and Avet-Loiseau H and Munshi N},
  year = {2018},
  journal = {Blood},
  doi = {10.1182/blood-2018-06-858613},
  url = {https://doi.org/10.1182/blood-2018-06-858613}
}

RIS

TY  - JOUR
TI  - Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
AU  - Perrot A
AU  - Lauwers-Cances V
AU  - Corre J
AU  - Robillard N
AU  - Hulin C
AU  - Chretien ML
AU  - Dejoie T
AU  - Maheo S
AU  - Stoppa AM
AU  - Pegourie B
AU  - Karlin L
AU  - Garderet L
AU  - Arnulf B
AU  - Doyen C
AU  - Meuleman N
AU  - Royer B
AU  - Eveillard JR
AU  - Benboubker L
AU  - Dib M
AU  - Decaux O
AU  - Jaccard A
AU  - Belhadj K
AU  - Brechignac S
AU  - Kolb B
AU  - Fohrer C
AU  - Mohty M
AU  - Macro M
AU  - Richardson PG
AU  - Carlton V
AU  - Moorhead M
AU  - Willis T
AU  - Faham M
AU  - Anderson KC
AU  - Harousseau JL
AU  - Leleu X
AU  - Facon T
AU  - Moreau P
AU  - Attal M
AU  - Avet-Loiseau H
AU  - Munshi N
PY  - 2018
JO  - Blood
DO  - 10.1182/blood-2018-06-858613
UR  - https://doi.org/10.1182/blood-2018-06-858613
ER  -

APA

A, P., V, L., J, C., N, R., C, H., ML, C., T, D., S, M., AM, S., B, P., L, K., L, G., B, A., C, D., N, M., B, R., JR, E., L, B., M, D., O, D., A, J., K, B., S, B., B, K., C, F., M, M., M, M., PG, R., V, C., M, M., T, W., M, F., KC, A., JL, H., X, L., T, F., P, M., M, A., H, A., & N, M. (2018). Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.. Blood. https://doi.org/10.1182/blood-2018-06-858613

Source records

pubmed · retrieved 2026-09-27T14:36:17.996Z
europe-pmc · retrieved 2026-09-27T14:36:18.018Z
hal · retrieved 2026-09-27T14:36:18.028Z